全部| 求助中| 待确认 按时间排序|按积分排序

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

用户TBS_MGy5GuJQ 1天前 10 待确认

Accelerating Effect of the Addition of HFIP on the Oxidation of Alcohols Using TEMPO/PIDA

用户fbBzZAqLjHfQ 1天前 10 待确认

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

答案Answerball 1天前 10 待确认

In vivo inhibition of Helicobacter pylori through probiotics and gastrointestinal commensals: a critical review

用户1oor83NH7Asw 1天前 10 待确认

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis

用户TBS_MGy5GuJQ 2天前 10 待确认

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

用户RcsoTKlzyIwM 2天前 20 待确认

CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity

用户RcsoTKlzyIwM 2天前 20 待确认

Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study

用户slK1Kxicm8Dw 2天前 10 待确认

Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel

用户1oor83NH7Asw 2天前 10 待确认

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors

用户NybQ738PJkRU 2天前 10 待确认
首页 上页 1 2 3 4 5 6 7 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com